Concord Biotech Ltd
BSE:
NSE:CONCORDBIO
CONCORDBIO Share Price
BSE:
NSE:CONCORDBIO
Pharmaceuticals
Large Cap
₹-
0 (0%)
Market Cap
₹23,683.02Cr
PE Ratio
72.21
Concord Biotech Ltd Performance
▲
▲
▲
▲
Concord Biotech Ltd Fundamentals
Concord Biotech Ltd Delivery and Volume
About Concord Biotech Ltd
Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies. Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16
| Name | Designation |
|---|---|
| SUDHIR JAIRAM VAID | Chairman & Managing Director |
| ANKUR VAID | Joint Managing Director & CEO |
| Ravi Kapoor | Non Executive Director |
| Rajiv Agarwal | Nominee |
| BHARTI KHANNA | Independent Director |
| Amitabh Thakore | Independent Director |
| Arvind Agarwal | Independent Director |
| Jayaram Easwaran | Independent Director |
| Mandayam Chakravarthy Sriraman | Independent Director |
| S Prakash | Assistant VP (Finance) & CS |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Concord Biotech Ltd FAQs
How do I Buy Concord Biotech Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Concord Biotech Ltd shares in BlinkX.
What is the Share Price of Concord Biotech Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Concord Biotech Ltd's share price is ₹2267.2 as of 2025-01-13.
What is the PE ratio of Concord Biotech Ltd?
Concord Biotech Ltd's P/E ratio is 72.21 times as of 2025-01-13.
What is the PB ratio of Concord Biotech Ltd?
Concord Biotech Ltd's most recent financial reports indicate a price-to-book ratio of 14.89, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Concord Biotech Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Concord Biotech Ltd's market capitalization is ₹23683.02 Cr as on 2025-01-13.
What is the ROE of Concord Biotech Ltd?
The current financial records of Concord Biotech Ltd show a 21.63% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Concord Biotech Ltd?
According to Concord Biotech Ltd's most recent financial filings, the company has a total asset value of ₹654.98, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Concord Biotech Ltd?
The 52-week high/low price of a Concord Biotech Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Concord Biotech Ltd's 52-week high and low as of 2025-01-13 are ₹2359 and ₹2187.25, respectively.
